Figshareopen access
Supplementary file 1_Adverse events associated with targeted therapy and immunotherapy for ovarian cancer: a FAERS pharmacovigilance study.docx
pharmacology, adverse events, bevacizumab, disproportionality analysis, ovarian cancer, parp inhibitors
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 300638
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.